PuSH - Publikationsserver des Helmholtz Zentrums München

178 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
21.
Lenk, L.* et al.: CD79a is associated with central nervous system infiltration of pediatric B-cell precursor acute lymphoblastic leukemia. Blood 132 (2018)
22.
Passerini, V.* et al.: PARP14 is a novel therapeutic target in STAT6 mutant follicular lymphoma. Blood 132 (2018)
23.
Stief, S.M.* et al.: Loss of KDM6A confers drug resistance in acute myeloid leukemia. Blood 132 (2018)
24.
Stripecke, R.* et al.: Pembrolizumab therapy exacerbates EBV-induced infections and tumors in a long-term fully humanized mouse model. Blood 132 (2018)
25.
Ward-Caviness, C.K. et al.: DNA methylation age is associated with an altered hemostatic profile in a multiethnic meta-analysis. Blood 132, 1842-1850 (2018)
26.
Cusan, M. et al.: Controlled stem cell amplification by HOXB4 depends on its unique proline-rich region near the N terminus. Blood 129, 319-323 (2017)
27.
Dai, B.* et al.: B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphoma. Blood 129, 333-346 (2017)
28.
Endele, M. et al.: CSF-1-induced Src signaling can instruct monocytic lineage choice. Blood 129, 1691-1701 (2017)
29.
Canli, Ö.* et al.: Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors. Blood 127, 139-148 (2016)
30.
Jacobsen, C.* et al.: HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma. Blood 128, 2517-2526 (2016)
31.
Kokkaliaris, K.D. et al.: Identification of factors promoting ex vivo maintenance of mouse hematopoietic stem cells by long-term single-cell quantification. Blood 128, 1181-1192 (2016)
32.
Saito, Y.* et al.: Peripheral blood CD34+ cells efficiently engraft human cytokine knock-in mice. Blood 128, 1829-1833 (2016)
33.
Stark, K.* et al.: Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice. Blood 128, 2435-2449 (2016)
34.
Toubiana, J.* et al.: Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype: An international survey of 274 patients from 167 kindreds. Blood 127, 3154-3164 (2016)
35.
Carlet, M. ; Vergalli, J. ; Finkenzeller, C. ; Grunert, M. & Jeremias, I.: The novel technique of Genetically Engineered Patient-Derived Xenografts (GEPDX) reveals that the X-linked Inhibitor of Apoptosis Protein (XIAP) plays an essential role for maintenance and growth of patients' acute lymphoblastic leukemia in vivo. Blood 126:2632 (2015)
36.
Deiser, K. et al.: Next-generation dendritic cell vaccination in postremission therapy of AML: Results of a clinical phase I trial. Blood 126:3805 (2015)
37.
Ebinger, S. et al.: Single cell RNA sequencing reveals increased adhesion signals in treatment-resistant tumor stem cells in a preclinical mouse model of genetically engineered patient-derived acute lymphoblastic leukemia. Blood 126:2630 (2015)
38.
Finkenzeller, C. ; Carlet, M. ; Vosberg, S.* ; Greif, P.A.* & Jeremias, I.: Functional diversity of single stem cell clones in patients' acute lymphoblastic leukemia growing in mice: An adverse subclone with distinct DNA-methylation pattern, slow growth in vivo and drug resistance. Blood 126:3062 (2015)
39.
Fischer, L. et al.: The novel CDK4/6-inhibitor abemaciclib induces early G1-arrest in MCL cell lines, sensitizes cells to cytarabine treatment and is additive with ibrutinib. Blood 126:5124 (2015)
40.
Freysoldt, B. et al.: Cotargeting of PIM, PI3K and Mtor in Mantle Cell Lymphoma (MCL). Blood 126:5120 (2015)